Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | ALNY | RVMD | ||
| Company | Csl Ltd ADR | Alnylam Pharmaceuticals | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 18.7200 | 280.11 | 160.65 | ||
| High | 19.2000 | 282.98 | 164.78 | ||
| Low | 18.5000 | 273.11 | 158.40 | ||
| Latest | 19.0000 | 278.09 | 162.99 | ||
| Change | +0.5900 | -4.63 | +5.22 | ||
| % Change | +3.20% | -1.64% | +3.31% | ||
| Volume | 371,600 | 2,204,700 | 4,702,500 | ||
| 20-Day Average Volume | 590,615 | 1,169,575 | 2,988,025 | ||
| Previous Close | 18.4100 | 282.72 | 157.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.7255 | 293.05 | 154.20 | ||
| 20-Day Raw Stochastic | 92.86% | 13.31% | 85.99% | ||
| 20-Day Relative Strength | 48.01 | 40.48 | 60.90 | ||
| Weighted Alpha | -53.73 | -23.37 | +151.51 | ||
| Today's Opinion | 88% Sell | 100% Sell | 100% Buy | ||
| Previous Opinion | 88% Sell | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.73% since 06/11/26 | -3.90% since 06/11/26 | +9.22% since 06/11/26 | ||
| Low | 18.4100 on 06/17/26 | 273.11 on 06/18/26 | 149.67 on 06/12/26 | ||
| High | 19.2300 on 06/17/26 | 291.28 on 06/12/26 | 164.78 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | +10.02% since 05/18/26 | -2.86% since 05/18/26 | +12.90% since 05/18/26 | ||
| Low | 16.0100 on 06/09/26 | 273.11 on 06/18/26 | 141.44 on 06/10/26 | ||
| High | 19.2300 on 06/17/26 | 310.53 on 06/04/26 | 166.50 on 06/01/26 | ||
| 3-Month | |||||
| %Chg | -20.70% since 03/18/26 | -11.66% since 03/18/26 | +66.13% since 03/18/26 | ||
| Low | 16.0100 on 06/09/26 | 273.11 on 06/18/26 | 91.52 on 03/30/26 | ||
| High | 26.6100 on 03/20/26 | 343.36 on 04/14/26 | 166.50 on 06/01/26 | ||
| 6-Month | |||||
| %Chg | -34.58% since 12/18/25 | -29.78% since 12/18/25 | +114.57% since 12/18/25 | ||
| Low | 16.0100 on 06/09/26 | 273.11 on 06/18/26 | 76.28 on 01/05/26 | ||
| High | 33.5316 on 02/10/26 | 427.05 on 01/07/26 | 166.50 on 06/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 36,397,312 | 37,128,632 | 34,651,024 | ||
| Shares Outstanding, K | 1,915,648 | 133,513 | 212,596 | ||
| Annual Sales | 15,558,000,000 | 3,713,940,000 | 0 | ||
| Annual Net Income | 3,002,000,000 | 313,750,000 | -1,131,300,000 | ||
| Last Quarter Sales | N/A | 1,167,180,000 | 0 | ||
| Last Quarter Net Income | N/A | 205,990,000 | -453,820,000 | ||
| 60-Month Beta | 0.61 | 0.29 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.99 on 04/30/26 | -2.29 on 05/06/26 | ||
| Earnings Date | 08/19/25 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | 0.294 on 03/11/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 03/11/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 77.46 | 0.00 | ||